Which has stronger earnings & valuation, CVRX or BBNX?

CVRx has higher earnings, but lower revenue than Beta Bionics. Beta Bionics is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CVRx $59.07M 2.43 -$53.31M -$2.02 N/A Beta Bionics $100.25M 6.17 -$73.20M -$1.51 N/A

Is CVRX or BBNX more profitable?

Beta Bionics has a net margin of -60.27% compared to CVRx's net margin of -89.14%. Beta Bionics' return on equity of -23.00% beat CVRx's return on equity. Company Net Margins Return on Equity Return on Assets CVRx -89.14% -120.76% -48.38% Beta Bionics -60.27% -23.00% -20.55%

Does the media refer more to CVRX or BBNX?

In the previous week, Beta Bionics had 17 more articles in the media than CVRx. MarketBeat recorded 19 mentions for Beta Bionics and 2 mentions for CVRx. CVRx's average media sentiment score of 0.00 beat Beta Bionics' score of 0.00 indicating that CVRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Beta Bionics 5 Very Positive mention(s) 0 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings & valuation, NPCE or CVRX?

NeuroPace has higher revenue and earnings than CVRx. NeuroPace is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio NeuroPace $99.99M 5.33 -$21.47M -$0.65 N/A CVRx $59.07M 2.43 -$53.31M -$2.02 N/A

Is NPCE or CVRX more profitable?

NeuroPace has a net margin of -21.67% compared to CVRx's net margin of -89.14%. NeuroPace's return on equity of -108.20% beat CVRx's return on equity. Company Net Margins Return on Equity Return on Assets NeuroPace -21.67% -108.20% -18.50% CVRx -89.14% -120.76% -48.38%

Does the media favor NPCE or CVRX?

In the previous week, NeuroPace had 1 more articles in the media than CVRx. MarketBeat recorded 3 mentions for NeuroPace and 2 mentions for CVRx. NeuroPace's average media sentiment score of 0.33 beat CVRx's score of 0.00 indicating that NeuroPace is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NeuroPace 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CVRx 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer CVRX or TCMD?

In the previous week, CVRx and CVRx both had 2 articles in the media. CVRx's average media sentiment score of 0.00 equaled Tactile Systems Technology'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Tactile Systems Technology 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable valuation & earnings, MDXG or CVRX?

MiMedx Group has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio MiMedx Group $418.63M 1.32 $48.58M $0.20 18.50 CVRx $59.07M 2.43 -$53.31M -$2.02 N/A

Is MDXG or CVRX more profitable?

MiMedx Group has a net margin of 7.88% compared to CVRx's net margin of -89.14%. MiMedx Group's return on equity of 21.03% beat CVRx's return on equity. Company Net Margins Return on Equity Return on Assets MiMedx Group 7.88% 21.03% 15.92% CVRx -89.14% -120.76% -48.38%

Does the media prefer MDXG or CVRX?

In the previous week, CVRx had 1 more articles in the media than MiMedx Group. MarketBeat recorded 2 mentions for CVRx and 1 mentions for MiMedx Group. MiMedx Group's average media sentiment score of 0.00 equaled CVRx'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MiMedx Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CVRx 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher valuation and earnings, CVRX or KIDS?

OrthoPediatrics has higher revenue and earnings than CVRx. OrthoPediatrics is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CVRx $59.07M 2.43 -$53.31M -$2.02 N/A OrthoPediatrics $236.35M 1.98 -$39.65M -$1.68 N/A

Is CVRX or KIDS more profitable?

OrthoPediatrics has a net margin of -16.31% compared to CVRx's net margin of -89.14%. OrthoPediatrics' return on equity of -7.01% beat CVRx's return on equity. Company Net Margins Return on Equity Return on Assets CVRx -89.14% -120.76% -48.38% OrthoPediatrics -16.31% -7.01% -4.86%

Does the media refer more to CVRX or KIDS?

In the previous week, CVRx and CVRx both had 2 articles in the media. CVRx's average media sentiment score of 0.00 equaled OrthoPediatrics'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral OrthoPediatrics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

CVRx (CVRX) Competitors

$5.40 +0.02 (+0.37%)

Closing price 06/8/2026 04:00 PM Eastern

Extended Trading

$5.49 +0.09 (+1.65%)

As of 07:57 AM Eastern

Compare

CVRX vs. BBNX, NPCE, TCMD, MDXG, and KIDS

Should you buy CVRx stock or one of its competitors? MarketBeat compares CVRx with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with CVRx include Beta Bionics (BBNX), NeuroPace (NPCE), Tactile Systems Technology (TCMD), MiMedx Group (MDXG), and OrthoPediatrics (KIDS). These companies are all part of the "medical equipment" industry.

How does CVRx compare to Beta Bionics?

CVRx (NASDAQ:CVRX) and Beta Bionics (NASDAQ:BBNX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk.

CVRx presently has a consensus target price of $11.50, indicating a potential upside of 112.96%. Beta Bionics has a consensus target price of $19.70, indicating a potential upside of 42.03%. Given CVRx's stronger consensus rating and higher possible upside, equities research analysts plainly believe CVRx is more favorable than Beta Bionics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	3.00
Beta Bionics	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.64

In the previous week, Beta Bionics had 17 more articles in the media than CVRx. MarketBeat recorded 19 mentions for Beta Bionics and 2 mentions for CVRx. CVRx's average media sentiment score of 0.00 beat Beta Bionics' score of 0.00 indicating that CVRx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CVRx	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Beta Bionics	5 Very Positive mention(s)	0 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

75.3% of CVRx shares are owned by institutional investors. 13.9% of CVRx shares are owned by insiders. Comparatively, 5.3% of Beta Bionics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

CVRx has higher earnings, but lower revenue than Beta Bionics. Beta Bionics is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$59.07M	2.43	-$53.31M	-$2.02	N/A
Beta Bionics	$100.25M	6.17	-$73.20M	-$1.51	N/A

CVRx has a beta of 0.8, meaning that its stock price is 20% less volatile than the broader market. Comparatively, Beta Bionics has a beta of 3.4, meaning that its stock price is 240% more volatile than the broader market.

Beta Bionics has a net margin of -60.27% compared to CVRx's net margin of -89.14%. Beta Bionics' return on equity of -23.00% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-89.14%	-120.76%	-48.38%
Beta Bionics	-60.27%	-23.00%	-20.55%

Summary

Beta Bionics beats CVRx on 9 of the 17 factors compared between the two stocks.

How does CVRx compare to NeuroPace?

NeuroPace (NASDAQ:NPCE) and CVRx (NASDAQ:CVRX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, profitability, dividends, media sentiment and analyst recommendations.

NeuroPace presently has a consensus price target of $18.83, suggesting a potential upside of 20.49%. CVRx has a consensus price target of $11.50, suggesting a potential upside of 112.96%. Given CVRx's stronger consensus rating and higher possible upside, analysts clearly believe CVRx is more favorable than NeuroPace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeuroPace	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.88
CVRx	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	3.00

NeuroPace has a net margin of -21.67% compared to CVRx's net margin of -89.14%. NeuroPace's return on equity of -108.20% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeuroPace	-21.67%	-108.20%	-18.50%
CVRx	-89.14%	-120.76%	-48.38%

In the previous week, NeuroPace had 1 more articles in the media than CVRx. MarketBeat recorded 3 mentions for NeuroPace and 2 mentions for CVRx. NeuroPace's average media sentiment score of 0.33 beat CVRx's score of 0.00 indicating that NeuroPace is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NeuroPace	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
CVRx	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

78.8% of NeuroPace shares are held by institutional investors. Comparatively, 75.3% of CVRx shares are held by institutional investors. 20.5% of NeuroPace shares are held by insiders. Comparatively, 13.9% of CVRx shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

NeuroPace has higher revenue and earnings than CVRx. NeuroPace is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeuroPace	$99.99M	5.33	-$21.47M	-$0.65	N/A
CVRx	$59.07M	2.43	-$53.31M	-$2.02	N/A

NeuroPace has a beta of 1.88, suggesting that its stock price is 88% more volatile than the broader market. Comparatively, CVRx has a beta of 0.8, suggesting that its stock price is 20% less volatile than the broader market.

Summary

NeuroPace beats CVRx on 13 of the 16 factors compared between the two stocks.

How does CVRx compare to Tactile Systems Technology?

CVRx (NASDAQ:CVRX) and Tactile Systems Technology (NASDAQ:TCMD) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, dividends, earnings, profitability, media sentiment and institutional ownership.

CVRx currently has a consensus target price of $11.50, indicating a potential upside of 112.96%. Tactile Systems Technology has a consensus target price of $38.60, indicating a potential upside of 52.87%. Given CVRx's stronger consensus rating and higher possible upside, equities analysts clearly believe CVRx is more favorable than Tactile Systems Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	3.00
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86

CVRx has a beta of 0.8, indicating that its share price is 20% less volatile than the broader market. Comparatively, Tactile Systems Technology has a beta of 0.83, indicating that its share price is 17% less volatile than the broader market.

75.3% of CVRx shares are held by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are held by institutional investors. 13.9% of CVRx shares are held by company insiders. Comparatively, 2.1% of Tactile Systems Technology shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Tactile Systems Technology has a net margin of 5.91% compared to CVRx's net margin of -89.14%. Tactile Systems Technology's return on equity of 9.70% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-89.14%	-120.76%	-48.38%
Tactile Systems Technology	5.91%	9.70%	7.53%

In the previous week, CVRx and CVRx both had 2 articles in the media. CVRx's average media sentiment score of 0.00 equaled Tactile Systems Technology'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CVRx	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Tactile Systems Technology	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Tactile Systems Technology has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$59.07M	2.43	-$53.31M	-$2.02	N/A
Tactile Systems Technology	$329.52M	1.73	$19.09M	$0.88	28.69

Summary

Tactile Systems Technology beats CVRx on 10 of the 15 factors compared between the two stocks.

How does CVRx compare to MiMedx Group?

MiMedx Group (NASDAQ:MDXG) and CVRx (NASDAQ:CVRX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends, media sentiment and earnings.

MiMedx Group has a beta of 1.48, indicating that its stock price is 48% more volatile than the broader market. Comparatively, CVRx has a beta of 0.8, indicating that its stock price is 20% less volatile than the broader market.

MiMedx Group presently has a consensus price target of $8.50, suggesting a potential upside of 129.73%. CVRx has a consensus price target of $11.50, suggesting a potential upside of 112.96%. Given MiMedx Group's higher probable upside, research analysts plainly believe MiMedx Group is more favorable than CVRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiMedx Group	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71
CVRx	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	3.00

MiMedx Group has a net margin of 7.88% compared to CVRx's net margin of -89.14%. MiMedx Group's return on equity of 21.03% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MiMedx Group	7.88%	21.03%	15.92%
CVRx	-89.14%	-120.76%	-48.38%

In the previous week, CVRx had 1 more articles in the media than MiMedx Group. MarketBeat recorded 2 mentions for CVRx and 1 mentions for MiMedx Group. MiMedx Group's average media sentiment score of 0.00 equaled CVRx'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MiMedx Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
CVRx	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

79.2% of MiMedx Group shares are owned by institutional investors. Comparatively, 75.3% of CVRx shares are owned by institutional investors. 2.5% of MiMedx Group shares are owned by insiders. Comparatively, 13.9% of CVRx shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

MiMedx Group has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiMedx Group	$418.63M	1.32	$48.58M	$0.20	18.50
CVRx	$59.07M	2.43	-$53.31M	-$2.02	N/A

Summary

MiMedx Group beats CVRx on 11 of the 16 factors compared between the two stocks.

How does CVRx compare to OrthoPediatrics?

CVRx (NASDAQ:CVRX) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, valuation, earnings, analyst recommendations and media sentiment.

CVRx currently has a consensus price target of $11.50, indicating a potential upside of 112.96%. OrthoPediatrics has a consensus price target of $24.44, indicating a potential upside of 34.09%. Given CVRx's stronger consensus rating and higher possible upside, equities analysts plainly believe CVRx is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	3.00
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.82

CVRx has a beta of 0.8, meaning that its share price is 20% less volatile than the broader market. Comparatively, OrthoPediatrics has a beta of 1.03, meaning that its share price is 3% more volatile than the broader market.

In the previous week, CVRx and CVRx both had 2 articles in the media. CVRx's average media sentiment score of 0.00 equaled OrthoPediatrics'average media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CVRx	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
OrthoPediatrics	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

OrthoPediatrics has higher revenue and earnings than CVRx. OrthoPediatrics is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$59.07M	2.43	-$53.31M	-$2.02	N/A
OrthoPediatrics	$236.35M	1.98	-$39.65M	-$1.68	N/A

OrthoPediatrics has a net margin of -16.31% compared to CVRx's net margin of -89.14%. OrthoPediatrics' return on equity of -7.01% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-89.14%	-120.76%	-48.38%
OrthoPediatrics	-16.31%	-7.01%	-4.86%

75.3% of CVRx shares are owned by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are owned by institutional investors. 13.9% of CVRx shares are owned by insiders. Comparatively, 31.8% of OrthoPediatrics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

OrthoPediatrics beats CVRx on 9 of the 15 factors compared between the two stocks.

Get CVRx News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CVRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CVRX vs. The Competition

Export

Metric	CVRx	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$142.76M	$7.18B	$6.47B	$11.98B
Dividend Yield	N/A	1.19%	2.67%	5.58%
P/E Ratio	-2.67	46.41	23.69	23.74
Price / Sales	2.43	84.16	533.79	119.57
Price / Cash	N/A	25.19	26.99	37.25
Price / Book	3.60	6.89	10.36	6.78
Net Income	-$53.31M	$159.22M	$3.57B	$337.51M
7 Day Performance	-0.55%	-2.53%	0.27%	-2.34%
1 Month Performance	-20.94%	2.25%	3.26%	1.88%
1 Year Performance	-13.32%	-3.61%	22.22%	25.55%

CVRx Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CVRX CVRx	2.0257 of 5 stars	$5.40 +0.4%	$11.50 +113.0%	-17.7%	$142.76M	$59.07M	N/A	160	Gap Down
BBNX Beta Bionics	3.0955 of 5 stars	$12.88 +0.6%	$19.70 +52.9%	-27.3%	$570.39M	$110.24M	N/A	294	Gap Down
NPCE NeuroPace	3.1589 of 5 stars	$16.42 -0.5%	$18.83 +14.7%	+18.9%	$563.91M	$99.99M	N/A	170
TCMD Tactile Systems Technology	3.3438 of 5 stars	$24.63 +2.7%	$38.60 +56.8%	+151.5%	$555.10M	$343.52M	27.05	1,086	Positive News
MDXG MiMedx Group	3.1233 of 5 stars	$3.58 -0.1%	$8.50 +137.8%	-43.0%	$533.23M	$389.42M	17.77	870	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CVRX) was last updated on 6/9/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CVRx (CVRX) Competitors